Characteristics and immunological changes of tumor-infiltrating lymphocytes during neoadjuvant chemo-immunotherapy in epithelial ovarian cancer

被引：0
|
作者：
Park, Junsik [1 ]
Kim, Yup [1 ]
Lee, Jung-Yun [2 ]
Kim, Sunghoon [1 ]
Lee, Yong Jae [1 ]
Kim, Sang Wun [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
[2] Yonsei Univ Hlth Syst, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
251
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [21] Changes in Tumor-infiltrating Lymphocytes After Neoadjuvant Chemotherapy and Clinical Significance in Triple Negative Breast Cancer
    Lee, Hyun
    Lee, Miseon
    Seo, Jeong-Han
    Gong, Gyungyub
    Lee, Hee Jin
    ANTICANCER RESEARCH, 2020, 40 (04) : 1883 - 1890
  • [22] Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy
    Lo, Charlotte S.
    Sanii, Sanaz
    Kroeger, David R.
    Milne, Katy
    Talhouk, Aline
    Chiu, Derek S.
    Rahimi, Kurosh
    Shaw, Patricia A.
    Clarke, Blaise A.
    Nelson, Brad H.
    CLINICAL CANCER RESEARCH, 2017, 23 (04) : 925 - 934
  • [23] Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
    Matsutani, Shinji
    Shibutani, Masatsune
    Maeda, Kiyoshi
    Nagahara, Hisashi
    Fukuoka, Tatsunari
    Nakao, Shigetomi
    Hirakawa, Kosei
    Ohira, Masaichi
    CANCER SCIENCE, 2018, 109 (04) : 966 - 979
  • [24] Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients
    Schondorf, T
    Engel, H
    Kurbacher, CM
    Brenne, U
    Kolhagen, H
    Gohring, UJ
    Scharl, A
    Mallmann, P
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 1998, 5 (02) : 102 - 107
  • [25] Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy
    Demaria, S
    Volm, MD
    Shapiro, RL
    Yee, HT
    Oratz, R
    Formenti, SC
    Muggia, F
    Symmans, WF
    CLINICAL CANCER RESEARCH, 2001, 7 (10) : 3025 - 3030
  • [26] ASO Video Abstract: Neoadjuvant Chemo-Immunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable NSCLC
    Chen, Tianxiang
    Cao, Zhengqi
    Sun, Yingjia
    Huang, Jia
    Shen, Shengping
    Jin, Yueping
    Jiang, Long
    Wen, Fengcai
    Zhao, Xiaochen
    Zhang, Ding
    Chen, Yanan
    Huang, Mengli
    Chen, Hao
    Lu, Shun
    Li, Ziming
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7599 - 7599
  • [27] Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy?
    Zito Marino, Federica
    Ascierto, Paolo Antonio
    Rossi, Giulio
    Staibano, Stefania
    Montella, Marco
    Russo, Daniela
    Alfano, Roberto
    Morabito, Alessandro
    Botti, Gerardo
    Franco, Renato
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 735 - 746
  • [28] Effect of tumor-infiltrating T-lymphocytes on the aggressiveness of epithelial ovarian tumors.
    Vasconcelos, Ines
    Olek, Sven
    Gellhaus, Katharina
    Schwachula, Tim
    Braicu, Ioana
    Fotopoulou, Christina
    Chekerov, Radoslav
    Dimitrova, Desislava
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] ASO Video Abstract: Neoadjuvant Chemo-Immunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable NSCLC
    Tianxiang Chen
    Zhengqi Cao
    Yingjia Sun
    Jia Huang
    Shengping Shen
    Yueping Jin
    Long Jiang
    Fengcai Wen
    Xiaochen Zhao
    Ding Zhang
    Yanan Chen
    Mengli Huang
    Hao Chen
    Shun Lu
    Ziming Li
    Annals of Surgical Oncology, 2023, 30 : 7599 - 7599
  • [30] Tumor-infiltrating Lymphocytes, Tumor Characteristics, and Recurrence in Patients With Early Breast Cancer
    Kim, Seung Tae
    Jeong, Hoiseon
    Woo, Ok Hee
    Seo, Jae Hong
    Kim, Aeree
    Lee, Eun Sook
    Shin, Sang Won
    Kim, Yeul Hong
    Kim, Jun Suk
    Park, Kyong Hwa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (03): : 224 - 231
12345